UPDATE : Wednesday, March 20, 2019
EzCareTech to speed up global presence with IPO
EzCareTech expressed its aspiration to become a global health networking le...
by Lee Han-soo  |  2019-03-06 14:58
Biogen seeks gene therapy pipeline for rare eye disease
The biotech industry is paying attention to whether Biogen’s recent acquisi...
by Kim Yun-mi  |  2019-03-06 14:41
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate
Genexine said Monday that I-Mab Biopharma, a Chinese bio-firm, has administ...
by Lee Han-soo  |  2019-03-06 14:27
Binex, Chongqing Zein to establish joint company
Binex said Wednesday that it has signed an agreement to establish a joint-v...
by Lee Han-soo  |  2019-03-06 13:41
Korea to crack down on illegal drugs amid ‘Burning Sun’ scandal
Nine government agencies have set about to crack down on the distribution o...
by Lee Hye-seon  |  2019-03-06 12:27
Europe OKs Samsung Bioepis’ biosimilar treatment of breast cancer
Samsung Bioepis said Tuesday that the European Medicines Agency has granted...
by Lee Han-soo  |  2019-03-05 17:53
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin
Medytox continued Tuesday to pressure Daewoong Pharmaceuticals to clarify s...
by Lee Han-soo  |  2019-03-05 16:22
Jeju Province to nullify approval for for-profit hospital
China’s Greenland Group requested Jeju Province to extend the deadline for ...
by Lee Min-ju  |  2019-03-05 16:22
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status
The Ministry of Food and Drug Safety has granted Hanmi’s HM43239, a treatme...
by Lee Han-soo  |  2019-03-05 15:34
Handok to market Amicus Therapeutics’ Fabry disease treatment
Handok said Tuesday that it has signed a local sales agreement with Amicus ...
by Lee Han-soo  |  2019-03-05 15:11
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment
Lilly Korea is to conduct a clinical trial on rheumatoid arthritis drug Olu...
by Lee Hye-seon  |  2019-03-05 15:10
3rd-generation antiepileptic drug lands on Korea
Briviact(ingredient: brivaracetam), a third-generation antiepileptic treatm...
by Lee Hye-seon  |  2019-03-05 14:42
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa
The International Vaccine Institute (IVI) said it has received a $3.2 milli...
by Lee Han-soo  |  2019-03-05 14:41
Oriental medicine practitioners hit record high in 2017
The number of Oriental medicine practitioners in the healthcare sector hit ...
by Lee Min-ju  |  2019-03-05 14:23
World’s 5th gastrointestinal endoscopy conference to kick off in Korea
The Korean Society of Gastrointestinal Endoscopy (KSGE) has organized the w...
by By Kim Yun-mi  |  2019-03-04 18:08
Hanmi releases P4 clinical trials for anti-hypertension treatment
Hanmi Pharmaceutical said Monday that it has published the results of phase...
by Lee Han-soo  |  2019-03-04 17:01
Minister Park calls for ‘closer international cooperation for patient safety’
Minister of Health and Welfare Park Neung-hu expressed an intention to help...
by Song Soo-youn  |  2019-03-04 17:00
Regulator expands XGEVA’s indication for use by multiple myeloma patients
Amgen’s XGEVA (denosumab), a treatment for reducing possibilities of skelet...
by Kim Yun-mi  |  2019-03-04 16:02
AbbVie gets positive views for treatment of plaque psoriasis in EU
AbbVie said Monday that the European Medicines Agency's Committee for M...
by Lee Han-soo  |  2019-03-04 15:57
‘Korea’s biopharma sector has sufficient potential’
A recognized “bio expert” has recently become the director-general of the B...
by Lee Hye-seon  |  2019-03-04 14:44
Back to Top